Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center ...
Apr 8, 2024
0
75
A new review paper from authors at Brigham and Women's Hospital and collaborators concludes that menopause does not uniformly elevate the risk of depression and other mental health conditions.
Mar 5, 2024
0
54
Dartmouth researchers report they have developed the first smartphone application that uses artificial intelligence paired with facial-image processing software to reliably detect the onset of depression before the user even ...
Feb 27, 2024
0
22
Maryam Shanechi and her team have developed a new machine learning method that reveals surprisingly consistent intrinsic brain patterns across different subjects by disentangling these patterns from the effect of visual inputs. ...
Feb 14, 2024
0
94
A major clinical trial has shown that by using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression, patients will see their symptoms ease for at least six months, ...
Jan 16, 2024
0
51
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, University of East London (UEL) and the University of Pennsylvania has used artificial intelligence to analyze the ...
Jan 12, 2024
0
40
A recent study published in Molecular Psychiatry has identified previously unknown alterations in neural connectivity that promote psychomotor disturbance—a slowing or reduction in movement—in individuals with major depressive ...
Jan 11, 2024
0
28
Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is ...
Jan 10, 2024
0
103
A pilot clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found electrical stimulation of the spinal cord is feasible, well-tolerated and shows therapeutic potential to treat depression.
Dec 20, 2023
0
72
Results from a Phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psilocybe, may benefit individuals with cancer and major depression. Trial participants treated ...
Dec 18, 2023
0
249
